Concurrent high dose radiotherapy and cisplatinum-based chemotherapy ± immunotherapy versus radiotherapy alone in esophageal carcinoma.: Molecular biology in assesment of response to chemoradiotherapy

被引：0
|
作者：
Ibrahim, SM
Ali, AK
Faraag, AA
Hamed, SE
Hafeez, ZMA
机构：
[1] Ain Shams Univ, Dept Radiat Oncol & Nucl Med, Fac Med, Cairo, Egypt
[2] Ain Shams Univ, Biochem & Tumor Biol Dept, Fac Med, Cairo, Egypt
[3] Ain Shams Univ, Dept Surg, Fac Med, Cairo, Egypt
来源：
EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷
关键词：
D O I：
10.1016/S0959-8049(99)80953-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
525
引用
收藏
页码：S143 / S144
页数：2
相关论文
共 36 条
  • [31] Tumor response and survival outcomes of salvage concurrent chemoradiotherapy with three-dimensional conformal radiotherapy and 5-fluorouracil/platinum-based chemotherapy for postoperative locoregional recurrence of esophageal squamous cell carcinoma
    Renma Ito
    Yoshiaki Nakamura
    Hironori Sunakawa
    Hisashi Fujiwara
    Hidehiro Hojo
    Naoki Nakamura
    Takeo Fujita
    Tomonori Yano
    Hiroyuki Daiko
    Tetsuo Akimoto
    Takayuki Yoshino
    Takashi Kojima
    Esophagus, 2022, 19 : 645 - 652
  • [32] A phase-II/III randomized controlled trial of adjuvant radiotherapy or concurrent chemoradiotherapy after surgery versus surgery alone in patients with stage-IIB/III esophageal squamous cell carcinoma
    Wenjie Ni
    Shufei Yu
    Wencheng Zhang
    Zefen Xiao
    Zongmei Zhou
    Dongfu Chen
    Qinfu Feng
    Jun Liang
    Jima Lv
    Shugeng Gao
    Yousheng Mao
    Qi Xue
    Kelin Sun
    Xiangyang Liu
    Dekang Fang
    Jian Li
    Dali Wang
    BMC Cancer, 20
  • [33] Response to "Comments on 'Radiotherapy alone versus concurrent chemoradiotherapy in patients with stage II and T3N0 nasopharyngeal carcinoma with adverse features: A propensity score-matched cohort study'"
    Zhang, Wei-Wei
    Guo, Rui
    RADIOTHERAPY AND ONCOLOGY, 2024, 197
  • [34] Progress report of a randomized trial comparing long-term survival and late toxicity of concurrent chemoradiotherapy with adjuvant chemotherapy versus radiotherapy alone in patients with stage III to IVB nasopharyngeal carcinoma from endemic regions of China
    Chen, Yong
    Sun, Ying
    Liang, Shao-Bo
    Zong, Jing-Feng
    Li, Wen-Fei
    Chen, Mo
    Chen, Lei
    Mao, Yan-Ping
    Tang, Ling-Long
    Guo, Ying
    Lin, Ai-Hua
    Liu, Meng-Zhong
    Ma, Jun
    CANCER, 2013, 119 (12) : 2230 - 2238
  • [35] High pathological response rate in locally advanced esophageal cancer after neoadjuvant combined modality therapy: dose finding of a weekly chemotherapy schedule with protracted venous infusion of 5-fluorouracil and dose escalation of cisplatin, docetaxel and concurrent radiotherapy
    Pasini, F
    de Manzoni, G
    Pedrazzani, C
    Grandinetti, A
    Durante, E
    Gabbani, M
    Tomezzoli, A
    Griso, C
    Guglielmi, A
    Pelosi, G
    Maluta, S
    Cetto, GL
    Cordiano, C
    ANNALS OF ONCOLOGY, 2005, 16 (07) : 1133 - 1139
  • [36] High-Dose Versus Standard-Dose Intensity- Modulated Radiotherapy With Concurrent Paclitaxel Plus Carboplatin for Patients With Thoracic Esophageal Squamous Cell Carcinoma: A Randomized, Multicenter, Open- Label, Phase 3 Superiority Trial
    You, Jing
    Zhu, Shuchai
    Li, Jiancheng
    Li, Jie
    Shen, Junyue
    Zhao, Yidian
    Li, Xiaomin
    Jia, Lin
    Li, Qingshan
    Yang, Jun
    Wu, Yiqun
    Shen, Wenbin
    Wu, Haishan
    Wu, Xueqin
    Wang, Xiaomin
    Ren, Yaqiong
    He, Jun
    Lin, Pingping
    Zhu, Guangying
    Shi, Anhui
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 115 (05): : 1129 - 1137
1234